opioid misuse – Notícias, Pesquisa e Análise – The Conversation

Todos os artigos de opioid misuse

30 novembro 2023

Buvidal: is it really a ‘game changer’ in the treatment of problematic opioid use?

Katy Holloway, University of South Wales e Fabrizio Schifano, University of Hertfordshire

Long-acting injectable buprenorphine is also known by the brand names Buvidal or Sublocade.

10 março 2021

Aili Langford, University of Sydney; Carl Schneider, University of Sydney; Christine Lin, University of Sydney e Danijela Gnjidic, University of Sydney

A one-dimensional approach to reducing opioid use isn’t favoured by health care professionals or patients.

13 maio 2020

Robert Tait, Curtin University; Aqif Mukhtar, Curtin University; Steve Allsop, Curtin University e Steve Whetton, University of Adelaide

A new report counts the social costs of pharmaceutical opioid misuse and illegal opioid use in Australia for 2015/2016. The numbers are fairly grim.

Steve Allsop
Professor, National Drug Research Institute, Curtin University
Robert Tait
Senior Research Fellow, National Drug Research Institute, Curtin University
Danijela Gnjidic
Associate Professor, School of Pharmacy, Faculty of Medicine and Health, University of Sydney, University of Sydney
Christine Lin
Professor, Institute for Musculoskeletal Health, University of Sydney
Carl Schneider
Associate professor, Sydney Pharmacy School, Faculty of Medicine and Health, University of Sydney
Steve Whetton
Deputy Director, SA Centre for Economic Studies, University of Adelaide
Aqif Mukhtar
Research Associate, Curtin University
Aili Langford
Bpharm (Hons), PhD Candidate School of Pharmacy, Faculty of Medicine and Health, University of Sydney
Katy Holloway
Professor of Criminology, University of South Wales
Fabrizio Schifano
Chair in Clinical Pharmacology and Therapeutics, University of Hertfordshire